Filter
594
Text search:
variant
Featured
Recommendations
67
New Publications
90
Language
Document type
No document type
213
Guidelines
135
Studies & Reports
129
Fact sheets
35
Manuals
25
Strategic & Response Plan
24
Situation Updates
16
Videos
6
Resource Platforms
5
Training Material
4
Brochures
1
Infographics
1
Countries / Regions
Global
27
India
26
Senegal
23
Brazil
21
Latin America and the Carribbean
15
South Africa
13
Burkina Faso
12
Congo, Democratic Republic of
12
Central African Republic
11
Western and Central Europe
11
Africa
11
Nigeria
8
Rwanda
8
Benin
8
West and Central Africa
8
Germany
7
Ukraine
7
Madagascar
7
Ethiopia
6
Togo
6
Kenya
6
Eastern Europe
6
Uganda
5
Philippines
5
South Sudan
5
Malawi
5
Mozambique
5
Myanmar / Burma
5
East and Southern Africa
5
Ghana
4
Haiti
4
Iraq
4
Russia
4
Cameroon
3
Niger
3
Zimbabwe
3
Chad
3
Bangladesh
3
Guatemala
3
Middle East and North Africa
3
Sierra Leone
2
Liberia
2
Mali
2
Morocco
2
Syria
2
China
2
Peru
2
Bolivia
2
Chile
2
Eastern Europe and Central Asia
2
Asia
2
Venezuela
2
France
2
Spain
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Nepal
1
Jordan
1
Afghanistan
1
Lebanon
1
Zambia
1
Turkey
1
Egypt
1
Tanzania
1
Cambodia
1
Indonesia
1
Mauritania
1
Sudan
1
Argentina
1
Dominican Republic
1
Namibia
1
Cuba
1
Burundi
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Mexico
1
Nicaragua
1
Yemen
1
South–East Asia Region
1
Western Pacific Region
1
Southern Africa
1
Congo-Brazzaville
1
Tajikistan
1
Qatar
1
Moldova
1
Iran
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
237
Clinical Guidelines
41
Public Health
22
Key Resources
16
Women & Child Health
12
Pharmacy & Technologies
12
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
COVID-19
206
Mental Health
40
HIV
23
Rapid Response
19
NTDs
15
Planetary Health
14
NCDs
12
TB
11
Global Health Education
11
AMR
10
Caregiver
10
Ebola
9
Cholera
8
Health Financing Toolbox
8
Disability
7
Natural Hazards
6
Pharmacy
6
Conflict
5
Refugee
5
Polio
3
Social Ethics
3
South Sudan
1
Zika
1
Specific Hazards
1
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1
...
The key to a lasting world free of all forms of poliovirus lies in rapidly interrupting all remaining endemic transmission of WPV in the endemic areas of Pakistan and Afghanistan. This is the only way to ensure that such strains do not re-emerge globally through international spread. It lays the cor
...
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat
...
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc
...
Weekly epidemiological update on COVID-19, 28 September 2022
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde
...
Временные рекомендации
9 августа 2021 г.
Цель данного документа - описать минимальный набор мероприятий по эпиднадзору, рекомендуемых на национальном уровне для вы
...
Orientaciones provisionales
9 de agosto de 2021
El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades pa
...
Annex. This document is an update of a guidance published on 12 July 2021, after the review of new scientific evidence on transmission of SARS-CoV-2 variants of concern (VOC). It contains updated recommendations on the use of masks and respirators for health workers providing care to suspected or c
...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Strengthening surveillance for Variant of Concern (VOC) Omicron (B.1.1.529): technical brief and priority actions for member states World Health Organization Headquarters, 28 November 2021
doi: https://doi.org/10.1101/2020.10.28.20221143
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Given the circulation of the variant of clade I of mpox virus (MPXV) in the African Region, which is associated in the African Region with sustained transmission and the occurrence of cases in a wider range of age groups, including children, the Pan
...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...